Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
New adverse drug reactions study findings have been reported from University of York
April 6th, 2008
Current study results from the report, 'A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery,' have been published. In this recent article published in the journal Health Technology Assessment, scientists in the United Kingdom conducted a study "To determine whether there is a level of methicillin-resistant Staphylococcus aureus (MRSA) prevalence at which a switch from non-glycopeptide to glycopeptide antibiotics for routine prophylaxis is indicated in surgical environments with a high risk of MRSA infection. Major electronic databases were searched up to September 2005." "REVIEW...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
